Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.

Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A, Kaisler J, Gisevius B, Gold R, Thum T, Haghikia A.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 1;6(6):e623. doi: 10.1212/NXI.0000000000000623. Print 2019 Nov.

2.

Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases.

Hirschberg S, Gisevius B, Duscha A, Haghikia A.

Int J Mol Sci. 2019 Jun 25;20(12). pii: E3109. doi: 10.3390/ijms20123109. Review.

3.

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis.

Vohl K, Duscha A, Gisevius B, Kaisler J, Gold R, Haghikia A.

Front Neurol. 2019 Feb 22;10:132. doi: 10.3389/fneur.2019.00132. eCollection 2019.

4.

Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration.

Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S, Linker RA, Gold R, Haghikia A.

Am J Pathol. 2017 Jul;187(7):1613-1622. doi: 10.1016/j.ajpath.2017.03.006.

5.

Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.

Massa MG, Gisevius B, Hirschberg S, Hinz L, Schmidt M, Gold R, Prochnow N, Haghikia A.

PLoS One. 2016 May 9;11(5):e0155274. doi: 10.1371/journal.pone.0155274. eCollection 2016.

Supplemental Content

Loading ...
Support Center